Automated quantification of choroidal neovascularization on Optical Coherence Tomography Angiography images.
Age-related macular degeneration
Choroidal neovascularization
Optical Coherence Tomography Angiography
Vascular segmentation
Vessel enhancement filtering
Journal
Computers in biology and medicine
ISSN: 1879-0534
Titre abrégé: Comput Biol Med
Pays: United States
ID NLM: 1250250
Informations de publication
Date de publication:
11 2019
11 2019
Historique:
received:
04
04
2019
revised:
06
09
2019
accepted:
14
09
2019
pubmed:
25
9
2019
medline:
29
9
2020
entrez:
25
9
2019
Statut:
ppublish
Résumé
To report the design of an automated quantification algorithm for choroidal neovascularization (CNV) in the context of neovascular age-related macular degeneration (AMD), based on Optical Coherence Tomography Angiography (OCTA) images. In this study, 54 patients (mean age 75.80 ± 14.29 years) with neovascular AMD (type 1 and type 2 CNV) were included retrospectively and separated into two groups (Group 1-24 images; Group 2-30 images), according to the lesion topology. All patients underwent a 3 × 3 mm OCTA examination (AngioVue, Optovue, Freemont, California). The proposed algorithm is based on segmentation and enhancement methods including Frangi filter, Gabor wavelets and Fuzzy-C-Means Classification. Our results were compared to the manual quantifications given by the embedded quantification software "AngioAnalytics". Automated CNV segmentation and quantification of three neovascular AMD biomarkers: the total vascular area (TVA), the total area (TA) and the vascular density (VD) were possible in all cases. Automated versus manual quantification comparison revealed a statistically significant difference for TVA and VD measurements for both groups (p = 0.00036 for Group 1 TVA, p < 0.0001 for Group 1 VD and Group 2 TVA and VD). The difference in TA measurements was not significant in Group 2 (p = 0.143). Bland-Altman analysis revealed low inter-method bias for TA measurements and higher bias for TVA and VD. This paper presents a method for segmenting and quantifying CNV that constitutes a valid option for clinicians. Complementary validations have to be carried out to compare our method's accuracy to "AngioAnalytics".
Identifiants
pubmed: 31550556
pii: S0010-4825(19)30326-9
doi: 10.1016/j.compbiomed.2019.103450
pii:
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
103450Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.